The aim of this study was to highlight the expression and the effects of IL-33/ST2 system, and particularly of sST2 in VSMCs and to determine whether sST2 could be a new biotarget reducing vascular remodeling associated with obesity. The gene discussed is IL33; the disease is Obesity.